← Back to Search

auto-adjusting positive airway pressure for Parkinson's Disease (COPE-PAP Trial)

N/A
Waitlist Available
Led By Marta Kaminska, MD, MSc
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months and 6 months
Awards & highlights

COPE-PAP Trial Summary

This trial will assess whether treating obstructive sleep apnea improves cognitive function in Parkinson's disease patients.

Eligible Conditions
  • Parkinson's Disease
  • Obstructive Sleep Apnea

COPE-PAP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in global cognitive function
Change in non-motor symptoms of Parkinson's disease
Change in quality of life
+1 more
Other outcome measures
REM sleep behaviour disorder

COPE-PAP Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Positive airway pressure (PAP)Experimental Treatment1 Intervention
Auto-adjusting positive airway pressure
Group II: nasal dilator stripsPlacebo Group1 Intervention
Sham treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
auto-adjusting positive airway pressure
2015
N/A
~100

Find a Location

Who is running the clinical trial?

American Thoracic SocietyOTHER
8 Previous Clinical Trials
561 Total Patients Enrolled
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
442 Previous Clinical Trials
159,083 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,341 Previous Clinical Trials
26,452,622 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025